GlobeNewswire
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020 -2030. The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the physicians' reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on AI-enabled medical imaging solutions market in the next five years, and the market will grow multifold. Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI-powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe. Market Report Coverage - AI-Enabled Medical Imaging Solutions Market Segmentation Therapeutic Application - Cardiology, Oncology (Breast, Lung, Other Cancer Types), Neurology, Respiratory, Orthopedic, and OthersModality - CT, MRI, X-Ray, Ultrasound, PET, Other ModalitiesWorkflow - Image Acquisition, Image Analysis, Detection, Diagnosis, and Treatment Decision Support, Predictive Analysis & Risk Assessment, Triage, Reporting and Communication, and Equipment Maintenance Regional Segmentation North America - U.S. and CanadaEurope - Germany, U.K, Italy, Spain, France, Switzerland, Sweden, Netherlands, and Rest of -EuropeAsia-Pacific - Japan, China, South Korea, Australia and New Zealand, Singapore, and Rest of -Asia -PacificRest-of-the-World Growth Drivers Increasing Complexities of Clinical Decision -MakingExpanding Range of ApplicationsShortage of Healthcare WorkforceHuge R&D investment Market Challenges Privacy and Security Concerns Related to Healthcare DataRegulatory ChallengesBarriers to Physician's Adoption of AILag in Regulatory ApprovalsLegal Implications of AI SystemsRise in Medical Imaging ExpensesData Security and Privacy IssuesLack of Trained Staff Market Opportunities Rapidly Evolving Deep Learning TechniquesIncreasing Number of Cross-Industry Partnerships Key Companies Profiled Siemens Healthineers AG., General Electric Company, Agfa - Gevart Group, Hologic, Inc., Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Nuance Communications, Inc., Synopsys Inc., NVIDIA Corporation, Nanox, Butterfly Network, Inc., Hyperfine. Aidoc, Arterys Inc, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, Envoy AI, MIRADA MEDICAL LIMITED, VUNO Inc., and Zebra Medical Vision, Inc. Key Questions Answered in this Report: What are the various AI-enabled medical imaging solutions and systems available in the market?What is the current market size and future potential of these products?What are the major market drivers, challenges, and opportunities in the global AI-enabled medical imaging solutions market?What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled medical imaging solutions?What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?Who are the leading players holding dominating shares in the global AI-enabled medical imaging solutions market, currently?What are the key strategies incorporated by the players of global AI-enabled medical imaging solutions market, to sustain the competition and retain their supremacy?What is the current revenue contribution of different therapeutic applications, workflow, and modality, and how would it evolve in the forecast period?What is the current demand contribution of different product types and how would it evolve in the forecast period?What is the current demand contribution of different deployment models and how would it evolve in the forecast period?Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled medical imaging solutions market? Key Topics Covered: 1 Product Definition 2 Research Scope 3 Research Methodology 4 Industry Insights4.1 Industry Ecosystem4.2 Legal Requirements and Regulations4.2.1 Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms4.2.1.1 Restraints in Current Regulatory Process for AI/ML-Based Medical Device/Algorithm4.2.2 Regulatory Framework in the U.S.4.2.3 Regulatory Framework in Europe4.2.3.1 Changes in Rule4.2.3.2 New Rules in the Annexure VIII4.2.3.3 Major Changes in the EU due to the Implementation of MDR:4.2.3.3.1 Expanded Device Definitions Requiring Re-Examination of the Current Classification of All Devices4.2.3.3.2 Quality Management System4.2.3.3.3 Technical File4.2.3.3.4 Need to Comply with New Identification and Traceability (UDI) Requirements4.2.3.3.5 More Emphasis on Post-Market Surveillance4.2.3.3.6 Need for Strengthening the Role of Internal Audits and Mandatory Audits4.2.3.3.7 Dedicated Personnel for MDR compliance4.2.4 Regulatory Framework in Japan4.2.5 Regulatory Framework in China4.2.6 Regulatory Framework in Other Countries4.2.6.1 Regulatory Framework in India4.2.6.2 Regulatory Framework in Latin America4.2.6.3 Regulatory Framework in the Middle East and Africa (MEA)4.2.7 Consortiums, Associations, and Regulatory Bodies4.3 Impact of COVID-194.3.1 Impact on Clinical Settings and Clinical Decision-Making4.3.2 Impact on AI-Based Medical Imaging Solution Manufacturers4.3.3 Conclusion 5 Real World Evidence5.1 Overview5.2 Aidoc5.2.1 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market5.3 Arterys Inc.5.3.1 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market5.4 Bay Labs, Inc.5.4.1 Role of Bay Labs, Inc. in the Global AI-Enabled Medical Imaging Solutions Market5.5 Heart Flow, Inc.5.5.1 Role of Heart Flow, Inc. in the Global AI-Enabled Medical Imaging Solutions Market5.6 MIRADA MEDICAL LIMITED5.6.1 Role of Mirada Medical Limited in the Global AI-Enabled Medical Imaging Solutions Market5.7 RADLogics Inc.5.7.1 Role of RADLogics Inc. in the Global AI-Enabled Medical Imaging Solutions Market5.8 VIDA Diagnostics, Inc.5.8.1 Role of VIDA Diagnostics, Inc. in the Global AI-Enabled Medical Imaging Solutions Market5.9 VUNO Inc.5.9.1 Role of VUNO lnc. in the Global AI-Enabled Medical Imaging Solutions Market5.1 Zebra Medical Vision, Inc.5.10.1 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market 6 Global AI-Enabled Medical Imaging Solutions Market Scenario6.1 Assumptions and Limitations6.2 Global Market Scenario6.3 Potential Market Opportunities6.3.1 Rapidly Evolving Deep Learning Techniques6.3.2 Increasing Number of Cross-Industry Partnerships6.4 Market Dynamics6.4.1 Impact Analysis6.4.2 Market Drivers6.4.2.1 Increasing Complexities of Clinical Decision-Making6.4.2.2 Expanding Range of Applications6.4.2.3 Shortage of Healthcare Workforce6.4.2.4 Huge R&D Investments6.4.3 Market Restraints6.4.3.1 Privacy and Security Concerns Related to Healthcare Data6.4.3.2 Regulatory Challenges6.4.3.3 Barriers to Physician's Adoption of AI6.4.3.4 Lag in Regulatory Approvals6.4.3.5 Legal Implications of AI Systems6.4.3.6 Rise in Medical Imaging Expenses6.4.3.7 Data Security and Privacy Issues6.4.3.8 Lack of Trained Staff 7 Competitive Landscape7.1 Key Strategies and Developments7.1.1 Joint Ventures, Collaborations, and Partnerships7.1.2 Funding and Investments7.1.3 Regulatory and Legal Activities.7.1.3.1 U.S. FDA Approvals7.1.3.2 CE Mark Approvals7.1.3.3 PMDA Approvals7.1.3.4 Others7.1.4 Product Launches and Enhancements7.1.5 Mergers and Acquisitions7.2 Growth Share Analysis7.2.1 Growth Share Matrix (by Product)7.2.2 Growth Share Matrix (by Workflow)7.2.3 Growth Share Matrix (by Modality) 8 Global AI-Enabled Medical Imaging Solutions Market (by Modality)8.1 Overview8.2 Computed Tomography (CT)8.3 Magnetic Resonance (MR)8.4 Ultrasound8.5 X-Ray8.6 Mammography8.7 Multimodality Imaging Systems8.8 Other Modalities 9 Global AI-Enabled Medical Imaging Solutions Market (by Product)9.1 Overview9.2 Software9.2.1 Perpetual Software License9.2.2 Subscription Software License9.2.3 Fee-Per Case Software License9.3 Hardware 10 Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model)10.1 Overview10.2 Cloud- and Web-Based Solutions10.3 On-Premises Solutions 11 Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2019-203011.1 Overview11.2 Image Acquisition11.3 Image Analysis11.4 Detection11.5 Diagnosis and Treatment Decision Support11.6 Predictive Analysis and Risk Assessment11.7 Triage11.8 Reporting and Communication 12 Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application)12.1 Overview12.2 Specialty Imaging12.2.1 Cardiology12.2.2 Oncology12.2.2.1 Lung Cancer12.2.2.2 Breast Cancer12.2.2.3 Other Cancer Types12.2.3 Neurology12.2.4 Respiratory12.2.5 Orthopedics12.2.6 Others12.3 General Imaging 13 Global AI-Enabled Medical Imaging Solutions Market (by Region)13.1 Overview13.2 North America13.3 Europe13.4 Asia-Pacific13.5 Rest-of-the-World (RoW) 14 Company Profiles14.1 Overview14.2 Agfa-Gevaert Group14.3 Butterfly Network, Inc.14.4 Fujifilm Holdings Corporation14.5 General Electric Company14.6 Hyperfine14.7 Hologic, Inc.14.8 Koninklije Philips N.V.14.9 Nanox14.1 Siemens Healthineers AG14.11 Aidoc14.12 Arterys Inc.14.13 Beijing Infervision Technology Co., Ltd.14.14 Blackford Analysis Limited14.15 Eureka Clinical AI, formerly known as EnvoyAI14.16 iCAD, Inc.14.17 MIRADA MEDICAL LIMITED14.18 Nuance Communications, Inc.14.19 NVIDIA Corporation14.2 Synopsys, Inc.14.21 VUNO lnc.14.22 Zebra Medical Vision, Inc. For more information about this report visit https://www.researchandmarkets.com/r/bclmf4 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900